Is the increase of uric acid associated with the components of the metabolic syndrome?

[1] National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106(25):3143–421.10.1161/circ.106.25.3143Search in Google Scholar

[2] Galiè N, Humbert M, Vachiery J-L, Gibbs S, Lang I, Torbicki A, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertensionThe Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016;37(1):67–119.10.1093/eurheartj/ehv317Search in Google Scholar

[3] Raikou VD, Gavriil S. Metabolic Syndrome and Chronic Renal Disease. Diseases 2018;6(1). pii: E12.10.3390/diseases6010012Search in Google Scholar

[4] Laucevičius A, Kasiulevičius V, Jatužis D, Petrulionienė Ž, RyliškytėL,Rinkūnienė E, et al. Lithuanian High Cardiovascular Risk (LitHiR) primary prevention programme – rationale and design. Semin Cardiovasc Med 2012;18:1–6.10.2478/v10287-012-0003-3Search in Google Scholar

[5] Zhang Q, Zhang C, Song X, Lin H, Zhang D, Meng W, et al. A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population. BMC Public Health 2012;12(1):419.10.1186/1471-2458-12-419Search in Google Scholar

[6] Wang H-J, Shi L-Z, Liu C-F, Liu S-M, Shi S-T. Association Between Uric Acid and Metabolic Syndrome in Elderly Women. Open Med 2018;13:172–7.10.1515/med-2018-0027Search in Google Scholar

[7] Lin S-D, Tsai D-H, Hsu S-R. Association Between Serum Uric Acid Level and Components of the Metabolic Syndrome. J Chin Med Assoc 2006;69(11):512–6.10.1016/S1726-4901(09)70320-XSearch in Google Scholar

[8] Kammar-García A, López-Moreno P, Blásquez-Gutiérrez ME, Hernández-Hernández ME, Ortiz-Bueno AM, Martínez-Montaño M de LC. Relationship of hyper-uricemia with metabolic alterations and cardiovascular risk factors in a population of Mexican young adults. Gac Mexico 2019;155(3):1898.10.24875/GMM.19004811Search in Google Scholar

[9] Brombo G, Bonetti F, Volpato S, Morieri ML, Napoli E, Bandinelli S, et al. Uric acid within the “normal” range predict 9-year cardiovascular mortality in older individuals. The InCHIANTI study. Nutr Metab Cardiovasc Dis 2019;29(10):1061–7.10.1016/j.numecd.2019.06.018674432931377184Search in Google Scholar

[10] Redon P, Maloberti A, Facchetti R, Redon J, Lurbe E, Bombelli M, et al. Gender-related differences in serum uric acid in treated hypertensive patients from central and east European countries: findings from the Blood Pressure control rate and CArdiovascular Risk profile study. J Hypertens 2019;37(2):380–8.10.1097/HJH.000000000000190830074564Search in Google Scholar

[11] Lim JH, Kim Y-K, Kim Y-S, Na S-H, Rhee M-Y, Lee M-M. Relationship between serum uric Acid levels, metabolic syndrome, and arterial stiffness in korean. Korean Circ J 2010;40(7):314–20.10.4070/kcj.2010.40.7.314291028720664739Search in Google Scholar

[12] Baygi F, Herttua K, Sheidaei A, Ahmadvand A, Jensen OC. Association of Serum Uric Acid with cardio-metabolic risk factors and metabolic syndrome in seafarers working on tankers. BMC Public Health 2020;20(1):442.10.1186/s12889-020-08466-2713301532248809Search in Google Scholar

[13] Ohyama Y, Imai K, Obokata M, Araki M, Sumiyoshi H, Koitabashi N, et al. Impact of uric acid on incident hypertension: Sex-specific analysis in different age groups. Int J Cardiol Hypertens 2019;2:100009.10.1016/j.ijchy.2019.100009780302033447742Search in Google Scholar

[14] Sui X, Church TS, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metab – Clin Exp 2008;57(6):845–52.10.1016/j.metabol.2008.01.030248683018502269Search in Google Scholar

[15] Tani S, Matsuo R, Imatake K, Suzuki Y, Takahashi A, Yagi T, et al. The serum uric acid level in females may be a better indicator of metabolic syndrome and its components than in males in a Japanese population. J Cardiol 2020; pii: S0914-5087(20)30030-7. doi: 10.1016/j.jjcc.2020.01.011.10.1016/j.jjcc.2020.01.01132107070Search in Google Scholar

[16] Zurlo A, Veronese N, Giantin V, Maselli M, Zambon S, Maggi S, et al. High serum uric acid levels increase the risk of metabolic syndrome in elderly women: The PRO.V.A study. Nutr Metab Cardiovasc Dis 2016;26(1):27–35.10.1016/j.numecd.2015.10.00726643208Search in Google Scholar

[17] Porchia LM, Gonzalez-Mejia ME, Torres-Rasgado E, Ruiz-Vivanco G, Pérez-Fuentes R. Low serum uric acid concentration augments insulin effects on the prevalence of metabolic syndrome. Diabetes Metab Syndr Clin Res Rev 2018;12(3):325–31.10.1016/j.dsx.2017.12.01229292186Search in Google Scholar

[18] Yu TY, Jee JH, Bae JC, Jin S-M, Baek J-H, Lee M-K, et al. Serum uric acid: A strong and independent predictor of metabolic syndrome after adjusting for body composition. Metabolism 2016;65(4):432–40.10.1016/j.metabol.2015.11.00326975535Search in Google Scholar

[19] Yuan H, Yu C, Li X, Sun L, Zhu X, Zhao C, et al. Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies. J Clin Endocrinol Metab 2015;100(11):4198–207.10.1210/jc.2015-252726308292Search in Google Scholar

[20] Yang T, Chu C-H, Bai C-H, You S-L, Chou Y-C, Chou W-Y, et al. Uric acid level as a risk marker for metabolic syndrome: A Chinese cohort study. Atherosclerosis 2012;220(2):525–31.10.1016/j.atherosclerosis.2011.11.01422154195Search in Google Scholar

[21] Nejatinamini S, Ataie-Jafari A, Qorbani M, Nikoohemat S, Kelishadi R, Asayesh H, et al. Association between serum uric acid level and metabolic syndrome components. J Diabetes Metab Disord 2015;14:70.10.1186/s40200-015-0200-z457052626380228Search in Google Scholar

[22] Wang L, Zhang T, Liu Y, Tang F, Xue F. Association of Serum Uric Acid with Metabolic Syndrome and Its Components: A Mendelian Randomization Analysis. BioMed Research International 2020;2020:6238693.10.1155/2020/6238693706387032258131Search in Google Scholar

[23] Weber MA, Drayer JI, Gray DR. Combined diuretic and sympatholytic therapy in elderly patients with predominant systolic hypertension. Chest 1983;83(2 Suppl):416–8.10.1378/chest.83.2.416Search in Google Scholar

[24] Raja R, Kavita F, Amreek F, Shah A, Sayeed KA, Sehar A. Hyperuricemia Associated with Thiazide Diuretics in Hypertensive Adults. Cureus 2019;11(8):e5457.10.7759/cureus.5457680280331641556Search in Google Scholar

[25] Gilowski W, Krysiak R, Marek B, Okopień B. The effect of short-term perindopril and telmisartan treatment on circulating levels of anti-inflammatory cytokines in hypertensive patients. Endokrynol Pol 2018;69(6):667–74.10.5603/EP.a2018.006830259507Search in Google Scholar

[26] Kansui Y, Ohtsubo T, Goto K, Sakata S, Ichishima K, Fukuhara M, et al. Association of serum uric acid with blood pressure in Japanese men. Cross-sectional study in work-site group. Circ J Off J Jpn Circ Soc 2011;75(12):2827–32.10.1253/circj.CJ-11-0592Search in Google Scholar

[27] Kuwabara M, Niwa K, Nishi Y, Mizuno A, Asano T, Masuda K, et al. Relationship between serum uric acid levels and hypertension among Japanese individuals not treated for hyperuricemia and hypertension. Hypertens Res 2014;37(8):785–9.10.1038/hr.2014.7524671018Search in Google Scholar

[28] Laucevičius A, Rinkūnienė E, Skujaitė A, Petrulionienė Ž, Puronaitė R, Dženkevičiūtė V, et al. Prevalence of cardiovascular risk factors in Lithuanian middle-aged subjects participating in the primary prevention program, analysis of the period 2009-2012. Blood Press 2015;24(1):41–7.10.3109/08037051.2014.96174425268930Search in Google Scholar

[29] Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004;4:9.10.1186/1471-2458-4-940650615043756Search in Google Scholar

[30] Wu Y, He H, Yu K, Zhang M, An Z, Huang H. The Association between Serum Uric Acid Levels and Insulin Resistance and Secretion in Prediabetes Mellitus: A Cross-Sectional Study. Ann Clin Lab Sci 2019;49(2):218–23.Search in Google Scholar

[31] Cheng D, Du R, Wu XY, Lin L, Peng K, Ma LN, et al. Serum Uric Acid is Associated with the Predicted Risk of Prevalent Cardiovascular Disease in a Community-dwelling Population without Diabetes. Biomed Environ Sci BES 2018;31(2):106–14.Search in Google Scholar

[32] Ford ES, Li C, Cook S, Choi HK. Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents. Circulation 2007;115(19):2526–32.10.1161/CIRCULATIONAHA.106.65762717470699Search in Google Scholar

[33] Juraschek SP, Kovell LC, Miller ER, Gelber AC. Association of kidney disease with prevalent gout in the United States in 1988–1994 and 2007–2010. Semin Arthritis Rheum 2013;42(6):551–61.10.1016/j.semarthrit.2012.09.009375485323312548Search in Google Scholar

[34] Jing J, Kielstein JT, Schultheiss UT, Sitter T, Titze SI, Schaeffner ES, et al. Prevalence and correlates of gout in a large cohort of patients with chronic kidney disease: the German Chronic Kidney Disease (GCKD) study. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc – Eur Ren Assoc 2015;30(4):613–21.10.1093/ndt/gfu35225395390Search in Google Scholar

[35] Al-Daghri NM, Al-Attas OS, Wani K, Sabico S, Alokail MS. Serum Uric Acid to Creatinine Ratio and Risk of Metabolic Syndrome in Saudi Type 2 Diabetic Patients. Sci Rep 2017;7(1):1–8.10.1038/s41598-017-12085-0560871828935934Search in Google Scholar

[36] Dobrzyńska M, Przysławski J. The relationship between serum uric acid concentration and cardiovascular risk factors in normotensivepostmenopausal women with dyslipidemia. Acta Sci Pol Technol Aliment 2020;19(1):123–31.10.17306/J.AFS.0740Search in Google Scholar

[37] Norvik JV, Storhaug HM, Ytrehus K, Jenssen TG, Zykova SN, Eriksen BO, et al. Overweight modifies the longitudinal association between uric acid and some components of the metabolic syndrome: The Tromsø Study. BMC Cardiovasc Disord 2016;16(1):85.10.1186/s12872-016-0265-8486221527165776Search in Google Scholar

[38] Seki S, Oki Y, Tsunoda S, Takemoto T, Koyama T, Yoshimura M. Impact of alcohol intake on the relationships of uric acid with blood pressure and cardiac hypertrophy in essential hypertension. J Cardiol 2016;68(5):447–54.10.1016/j.jjcc.2015.11.00626690739Search in Google Scholar

[39] Howes LG, Reid JL. The effects of alcohol on local, neural and humoral cardiovascular regulation. Clin Sci Lond Engl 1979 1986;71(1):9–15.10.1042/cs0710009Search in Google Scholar